Ofatumumab in Combination With Glucocorticoids for Primary Therapy of Chronic Graft Versus Host Disease
Active, no longer recruiting
Phase of Trial: Phase I/II
Latest Information Update: 01 Sep 2017
At a glance
- Drugs Ofatumumab (Primary) ; Prednisone
- Indications Graft-versus-host disease
- Focus Adverse reactions
- 29 Aug 2017 Planned End Date changed from 1 Mar 2018 to 1 Jun 2019.
- 29 Aug 2017 Planned primary completion date changed from 1 Mar 2018 to 1 Jun 2018.
- 29 Aug 2017 Status changed from recruiting to active, no longer recruiting.